1-3 of 3
Olga Fedorova
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1568: Mechanistic studies of KL-50, a novel imidazotetrazine for the treatment of MGMT-/MMR- gliomas and glioblastoma

Eric D. Huseman, Anna Lo, Olga Fedorova, Kingson Lin, Susan Gueble, Ranjini Sundaram, Anna M. Pyle, Ranjit S. Bindra, Seth Herzon
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 1568.
https://doi.org/10.1158/1538-7445.AM2023-1568
Published: 04 April 2023
View article titled, Abstract 1568: Mechanistic studies of KL-50, a novel imidazotetrazine for the treatment of MGMT-/MMR- gliomas and glioblastoma
Journal Articles

Abstract 1237: Zeb1-mediated autophagy enhances resistance of breast cancer cells to genotoxic drugs

Nick A. Barlev, Olga Fedorova, Alexandra Daks, Eugene M. Tulchinsky
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 1237.
https://doi.org/10.1158/1538-7445.AM2023-1237
Published: 04 April 2023
View article titled, Abstract 1237: Zeb1-mediated autophagy enhances resistance of breast cancer cells to genotoxic drugs
Journal Articles

Therapeutically Active RIG-I Agonist Induces Immunogenic Tumor Cell Killing in Breast Cancers

David L. Elion, Max E. Jacobson, Donna J. Hicks, Bushra Rahman, Violeta Sanchez, Paula I. Gonzales-Ericsson, Olga Fedorova, Anna M. Pyle, John T. Wilson, Rebecca S. Cook
Journal: Cancer Research
Series: Author Choice
Cancer Res (2018) 78 (21): 6183–6195.
https://doi.org/10.1158/0008-5472.CAN-18-0730
Published: 01 November 2018
View article titled, Therapeutically Active RIG-I Agonist Induces Immunogenic Tumor Cell Killing in Breast Cancers
Open the PDF for Therapeutically Active RIG-I Agonist Induces Immunogenic Tumor Cell Killing in Breast Cancers in another window
Includes: Supplementary data